People: Adeona Pharmaceuticals, Inc. (AEN)

Mr. Steve H. Kanzer, CPA, JD. is Chairman of the Board of Adeona Pharmaceuticals, Inc. Mr. Kanzer is the company co-founder and has been the company's Chairman since September 2004. He served as the company's President from the company's inception in February 2001 until May 2006 and as the company's Chief Executive Officer from September 2004 through July 2008. He served as the company's interim Chief Executive Officer from April 2009 to June 2009. Mr. Kanzer serves on a full-time basis at the company corporate headquarters in Ann Arbor, Michigan. Mr. Kanzer has also been a director and officer of thr company subsidiaries, including Solovax, Inc., Effective Pharmaceuticals, Inc., Putney Drug Corp. and CD4 Biosciences, Inc. Since December 2000, he has served as co-founder and Chairman of Accredited Ventures Inc. and Accredited Equities Inc., a venture capital firm and FINRA-member investment bank, respectively, which both specialize in the biotechnology industry. Mr. Kanzer was co-founder, Chairman, President and Chief Executive Officer of Developmental Therapeutics, Inc., a cardiovascular drug development company which was developing an oral thyroid hormone analog, DITPA, for congestive heart failure. Developmental Therapeutics was acquired in October 2003 by Titan Pharmaceuticals, Inc., a publicly traded biopharmaceutical company. Prior to founding Accredited Ventures and Accredited Equities in December 2000, Mr. Kanzer served as Senior Managing Director-Head of Venture Capital at Paramount Capital from 1991 until December 2000.Mr. Kanzer received his J.D. from New York University School of Law in 1988 and a B.B.A. in Accounting from Baruch College in 1985, where he was a Baruch Scholar. Mr. Kanzer is active in university-based pharmaceutical technology licensing and has served as Co-Chair of the New York Chapter of the Licensing Executives Society.